Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 22, 2023
Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials
Adam C Levine, Yuriko Fukuta, Moises A Huaman, et al.
The Lancet. Haematology
|
March 31, 2022
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial
David I Marks, Amy A Kirkwood, Clare J Rowntree, et al.
Cell
|
November 21, 2018
Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer
Hanghang Zhang, Somnath Pandey, Meghan Travers, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 29, 2025
Treatment with Allogenic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multi-Center, Phase 2b Clinical Trial (STAT)
Michael A Matthay, Hanjing Zhou, Aartik Sarma, et al.
Annals of Internal Medicine
|
March 20, 2023
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
Tracy Y Wang, Abdus S Wahed, Alison Morris, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 9, 2022
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern
Maggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Transfusion
|
March 30, 2022
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?
Evan M Bloch, Aaron A R Tobian, Shmuel Shoham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 29, 2023
A Multicenter Retrospective Cohort Study to Characterize Patients Hospitalized With Multisystem Inflammatory Syndrome in Adults and Coronavirus Disease 2019 in the United States, 2020-2021
Michael Melgar, Joseph Y Abrams, Shana Godfred-Cato, et al.
Blood Advances
|
April 20, 2022
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
Maggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Blood
|
April 25, 2021
Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL
Elisabeth Paietta, Kathryn G Roberts, Victoria Wang, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 22, 2023
Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials
Adam C Levine, Yuriko Fukuta, Moises A Huaman, et al.
The Lancet. Haematology
|
March 31, 2022
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial
David I Marks, Amy A Kirkwood, Clare J Rowntree, et al.
Cell
|
November 21, 2018
Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer
Hanghang Zhang, Somnath Pandey, Meghan Travers, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 29, 2025
Treatment with Allogenic Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome: A Double-Blind, Placebo-controlled, Multi-Center, Phase 2b Clinical Trial (STAT)
Michael A Matthay, Hanjing Zhou, Aartik Sarma, et al.
Annals of Internal Medicine
|
March 20, 2023
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
Tracy Y Wang, Abdus S Wahed, Alison Morris, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 9, 2022
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern
Maggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Transfusion
|
March 30, 2022
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?
Evan M Bloch, Aaron A R Tobian, Shmuel Shoham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 29, 2023
A Multicenter Retrospective Cohort Study to Characterize Patients Hospitalized With Multisystem Inflammatory Syndrome in Adults and Coronavirus Disease 2019 in the United States, 2020-2021
Michael Melgar, Joseph Y Abrams, Shana Godfred-Cato, et al.
Blood Advances
|
April 20, 2022
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
Maggie Li, Evan J Beck, Oliver Laeyendecker, et al.
Blood
|
April 25, 2021
Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL
Elisabeth Paietta, Kathryn G Roberts, Victoria Wang, et al.
Page
of 11